Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics
The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Abstract
The clinical events resulting from atherosclerosis are directly related to the oxidation of lipids in LDLs that become trapped in the extracellular matrix of the subendothelial space. These oxidized lipids activate an NFκB-like transcription factor and induce the expression of genes containing NFκB binding sites. The protein products of these genes initiate an inflammatory response that initially leads to the development of the fatty streak. The progression of the lesion is associated with the activation of genes that induce arterial calcification, which changes the mechanical characteristics of the artery wall and predisposes to plaque rupture at sites of monocytic infiltration. Plaque rupture exposes the flowing blood to tissue factor in the lesion, and this induces thrombosis, which is the proximate cause of the clinical event. There appear to be potent genetically determined systems for preventing lipid oxidation, inactivating biologically important oxidized lipids, and/or modulating the inflammatory response to oxidized lipids that may explain the differing susceptibility of individuals and populations to the development of atherosclerosis. Enzymes associated with HDL may play an important role in protecting against lipid oxidation in the artery wall and may account in part for the inverse relation between HDL and risk for atherosclerotic clinical events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries
Glagov, S., Weisenberg, E., Zarins, C. K., Stankunavicius, R., & Kolettis, G. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162204 · Cited by 3,623
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Cited by
Items 101–133 of 133
Aviram, M., Rosenblat, M., Bisgaier, C. L., & Newton, R. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00032-x · Cited by 296
Shah, P. K., Kaul, S., Nilsson, J., & Cercek, B. (2001) · Circulation · doi:10.1161/hc4501.098468 · Cited by 295
Collins, E. J., Bowyer, C., Tsouza, A., & Chopra, M. (2022) · Biology · doi:10.3390/biology11020239 · Cited by 293
Lee, H., Shi, W., Tontonoz, P., Wang, S., Subbanagounder, G., Hedrick, C. C., Hama, S., Borromeo, C., Evans, R. M., Berliner, J. A., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.6.516 · Cited by 292
Self-citationCiccone, M. M., Cortese, F., Gesualdo, M., Carbonara, S., Zito, A., Ricci, G., De Pascalis, F., Scicchitano, P., & Riccioni, G. (2013) · Mediators of Inflammation · doi:10.1155/2013/782137 · Cited by 290
Li, P.-F., Dietz, R., & von Harsdorf, R. (1997) · Circulation · doi:10.1161/01.cir.96.10.3602 · Cited by 288
Yoshida, H., & Kisugi, R. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.08.038 · Cited by 288
The role of taurine in diabetes and the development of diabetic complications
Hansen, S. H. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.229 · Cited by 281
Virtamo, J., Rapola, J. M., Ripatti, S., Heinonen, O. P., Taylor, P. R., Albanes, D., & Huttunen, J. K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.668 · Cited by 279
The role of psychobiological pathways in socio-economic inequalities in cardiovascular disease risk
Steptoe, A. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2611 · Cited by 274
Mackowiak, P. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1870 · Cited by 254
Chronic Inflammatory Diseases and Endothelial Dysfunction
Castellon, X., & Bogdanova, V. (2016) · Aging and disease · doi:10.14336/ad.2015.0803 · Cited by 191
“Causes that promote oxidative stress are: hypoxia, respiratory diseases favored by repeated pulmonary infections, smoking, frequent exposure to the sun, alcohol and air pollution [13-16].”
BackgroundAir pollution and circulating biomarkers of oxidative stress
Delfino, R. J., Staimer, N., & Vaziri, N. D. (2011) · Air Quality, Atmosphere & Health · doi:10.1007/s11869-010-0095-2 · Cited by 181
“Circulating oxLDL has been suggested to be involved in the upregulation of inflammatory genes (Berliner et al. 1995) and expression of cytokines in human blood (Hulthe and Fagerberg 2002).”
BackgroundRole of Tumor Necrosis Factor-α in Methamphetamine-Induced Drug Dependence and Neurotoxicity
Nakajima, A., Yamada, K., Nagai, T., Uchiyama, T., Miyamoto, Y., Mamiya, T., He, J., Nitta, A., Mizuno, M., Tran, M. H., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4847-03.2004 · Cited by 176
Ribeiro, F., Alves, A. J., Duarte, J. A., & Oliveira, J. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.09.548 · Cited by 169
Hsueh, Y.-M., Wu, W.-L., Huang, Y.-L., Chiou, H.-Y., Tseng, C.-H., & Chen, C.-J. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00178-6 · Cited by 159
Large animal models of cardiovascular disease
Tsang, H. G., Rashdan, N. A., Whitelaw, C. B. A., Corcoran, B. M., Summers, K. M., & MacRae, V. E. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3173 · Cited by 154
Shaw, P. X., Zhang, L., Zhang, M., Du, H., Zhao, L., Lee, C., Grob, S., Lim, S. L., Hughes, G., Lee, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121309109 · Cited by 148
“, activating NFκB-like factors) in vascular cells that subsequently lead to the initiation and maintenance of an inflammatory response (41).”
BackgroundEndothelial dysfunction in hypopituitary adults with growth hormone deficiency
Evans, M., Davies, Goodfellow, Rees, & Scanlon (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00671.x · Cited by 129
Napoli, C., Witztum, J. L., de Nigris, F., Palumbo, G., D’Armiento, F. P., & Palinski, W. (1999) · Circulation · doi:10.1161/01.cir.99.15.2003 · Cited by 110
Gurven, M., Kaplan, H., Winking, J., Eid Rodriguez, D., Vasunilashorn, S., Kim, J. K., Finch, C., & Crimmins, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006590 · Cited by 107
“, cholesteryl ester transport protein (CETP)] [52], lipid oxidation, and modulation of the inflammatory response to oxidized lipids may also help explain differences in susceptibility of populations to developing atherosclerosis [53].”
BackgroundEffects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
Punch, E., Klein, J., Diaba‐Nuhoho, P., Morawietz, H., & Garelnabi, M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023328 · Cited by 101
Montero, M. T., Hernández, O., Suárez, Y., Matilla, J., Ferruelo, A. J., Martı́nez-Botas, J., Gómez-Coronado, D., & Lasunción, M. A. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00417-2 · Cited by 97
Khodabandehlou, K., Masehi-Lano, J. J., Poon, C., Wang, J., & Chung, E. J. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217693116 · Cited by 91
Mooradian, A. D., Haas, M. J., & Wong, N. C. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0013 · Cited by 91
Sinha, S. K., Miikeda, A., Fouladian, Z., Mehrabian, M., Edillor, C., Shih, D., Zhou, Z., Paul, M. K., Charugundla, S., Davis, R. C., et al. (2021) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.120.315255 · Cited by 88
Self-citationAn Updated Systematic Review on the Effects of Aerobic Exercise on Human Blood Lipid Profile
Doewes, R. I., Gharibian, G., zadeh, F. A., Zaman, B. A., vahdat, S., & Akhavan-Sigari, R. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101108 · Cited by 85
Pihl, E., Zilmer, K., Kullisaar, T., Kairane, C., Mägi, A., & Zilmer, M. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803068 · Cited by 84
Hegele, R. A., Gidding, S. S., Ginsberg, H. N., McPherson, R., Raal, F. J., Rader, D. J., Robinson, J. G., & Welty, F. K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306442 · Cited by 63
Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans
Soto, Y., Acosta, E., Delgado, L., Pérez, A., Falcón, V., Bécquer, M. A., Fraga, Á., Brito, V., Álvarez, I., Griñán, T., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.238659 · Cited by 41
Bellido, C., López-Miranda, J., Pérez-Martínez, P., Paz, E., Marín, C., Gómez, P., Moreno, J. A., Moreno, R., & Pérez-Jiménez, F. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.09.007 · Cited by 25
Johns, D. G., Ao, Z., Eybye, M., Olzinski, A., Costell, M., Gruver, S., Smith, S. A., Douglas, S. A., & Macphee, C. H. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090993 · Cited by 22
MMP‐2 inhibits PCSK9‐induced degradation of the LDL receptor in Hepa1‐c1c7 cells
Wang, X., Berry, E., Hernandez-Anzaldo, S., Sun, D., Adijiang, A., Li, L., Zhang, D., & Fernandez-Patron, C. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.01.007 · Cited by 15
Metadata
- Authors
- Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J.
- Venue
- Circulation
- Published
- 1995-05
- Volume
- 91
- Issue
- 9
- Pages
- 2488-2496
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2156255102
- Cited by
- 1,701
- References
- 114
- FWCI
- 28.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.